Welcome to the e-CCO Library Archive!

search
                             
search by: 
Filter:
P110. Surveillance for colorectal cancer in colitis patients: effect of the implementation of new British and American guidelines on neoplasia yield
Authors:

E. Mooiweer1, A.E. van der Meulen2, A.A. van Bodegraven3, J.M. Jansen4, N. Mahmmod5, J. Nijsten1, M.G. van Oijen1, P.D. Siersema1, B. Oldenburg1, 1University Medical Centre Utrecht, Department of Gastroenterology and Hepatology, Utrecht, Netherlands, 2Leiden University Medical Centre, Department of Gastroenterology and Hepatology, Leiden, Netherlands, 3VU University Medical Centre, Department of Gastroenterology and Hepatology, Amsterdam, Netherlands, 4OLVG, Department of Gastroenterology and Hepatology, Amsterdam, Netherlands, 5Antonius Hospital, Department of Gastroenterology and Hepatology, Nieuwegein, Netherlands

P110. Validation of a fast genotyping method for analysis of TPMT polymorphisms
P110. Virtual chromoendoscopy with i‑scan for diagnosis of mucosal healing in patients with inflammatory bowel disease – a prospective randomized double-blind controlled study
P110

Usefulness of magnifying endoscopy for diagnosis of colitis-associated intraepithelial neoplasia in patients with ulcerative colitis

Authors:

M. Naganuma*1, Y. Iwao*2, T. Hisamatsu3, H. Ogata1, T. Kanai3

1Keio University, Center for Diagnostic and Therapeutic Endoscopy, Tokyo, Japan, 2Keio University School of Medicine, Center for Preventive Medicine, Tokyo, Japan, 3Keio University, Gastroenterology and Hepatology, Tokyo, Japan

P111. “EARS” (Erlanger Activity Related Score) of IBD: A new tool that allows accurate in vivo assessment of inflammatory activity in ulcerative colitis
P111.

The usefulness of intestinal real time virtual sonography in patients with inflammatory bowel disease

Authors:

S. Kawai, H. Iijima, S. Shinzaki, M. Araki, E. Shiraishi, S. Hiyama, T. Inoue, T. Nishida, M. Tsujii, T. Takehara, Osaka University Graduate School of Medicine, Department of Gastroenterology and Hepatology, 2–2 Yamadaoka, Suita, Osaka, Japan

P111. Arterial stiffness in patients with inflammatory bowel diseases
P111. Pulmonary involvement in Crohn's disease patients
Authors:

M. Di Girolamo1, A. Scarcelli1, A. Bertani1, A. Sartini1, A. Merighi1, C. Ruggiero1, U. Morandi1, E. Villa1, 1Policlinico Modena, Italy

P111

Are extraintestinal manifestations associated with disease outcomes in Ulcerative Colitis? Results from a population-based inception cohort between 2002-2012

Authors:

P.A. Golovics*1, B. Lovasz1, Z. Vegh1, I. Szita2, M. Balogh3, S. Vavricka4, G. Rogler4, L. Lakatos2, P. Lakatos1

1Semmelweis University, 1st Department of Medicine, Budapest, Hungary, 2Csolnoky F. Province Hospital, Department of Medicine, Veszprem, Hungary, 3Grof Eszterhazy Hospital, Department of Medicine, Papa, H`ungary, 4University Hospital Zurich, Department of Internal Medicine, Division of Gastroenterology and Hepatology, Zurich, Switzerland

P112.

The triggering role of Clostridium difficile infection in the relapse of IBD and the clinical utility of fecal calprotectin and matrix-metallo­proteinase-9 in case of Clostridium-induced relapse

Authors:

A. Balint1, M. Szucs2, K. Farkas1, E. Urbán3, F. Nagy1, Z. Szepes1, T. Wittmann1, T. Molnár1, 1University of Szeged, First Department of Medicine, Szeged, Hungary, 2University of Szeged, Department of Medical Physics and Informatics, Szeged, Hungary, 3University of Szeged, Institute of Clinical Microbiology, Szeged, Hungary

P112. Different production of soluble HLA-G antigens by peripheral blood mononuclear cells in ulcerative colitis and Crohn's disease
P112. iSCAN-High definition colonoscopy correlates with white light endoscopy and histology assessment in mucosal healing for ulcerative colitis
Authors:

M. Iacucci1, M. Fort Gasia1, X. Gui2, R. Panaccione1, G. Kaplan1, J. Love1, S. Ghosh1, 1University of Calgary, Gastroenterology, Calgary, Canada, 2University of Calgary, Pathology, Calgary, Canada

P112. The natural history of Crohn's disease (CD): A long-term (>10 years) follow-up study
P112

Effectiveness of "Hospital Anxiety and Depression Scale" for the screening of the psychiatric treatment need in outpatients with Inflammatory Bowel Diseases

Authors:

O. Yanatas1, H.T. Kani2, M. Banzragch3, E. Bicakci3, K. Kuscu1, O. Atug3, N. Imeryuz3, H. Akin*3

1Marmara University, School of Medicine, Psychiatry, Istanbul, Turkey, 2Marmara University, School of Medicine, Internal Medicine, Istanbul, Turkey, 3Marmara University, Gastroenterology, Istanbul, Turkey

P113.

The lived experience of attending a formal inflammatory bowel disease patient education programme. A phenomenological study

Authors:

M. Sephton1, K. Kemp2, V. Ridgway3, 1University Hospital of South Manchester, Gastroenterology, Wythenshawe, Manchester, United Kingdom, 2University of Manchester, School of Nursing, Manchester, United Kingdom, 3University of Chester, Department of Health & Social Care, Chester, United Kingdom

P113. Calprotectin for relapse risk assessment in teenagers with inflammatory bowel disease who claim to have full disease control
P113. Factors affecting Swedish patients' refill adherence and persistence to adalimumab therapy
P113. Granuloma is associated with poor outcome in Crohn's disease patients after surgical bowel resection
Authors:

Y.M. Han1, J.W. Kim2, J.M. Choi1, S.-J. Koh2, C. Lee1, S.H. Kim2, J.P. Im1, 1Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, South Korea, 2Department of Internal Medicine, Seoul National University Boramae Hospital, Seoul National University College of Medicine, Seoul, South Korea

P113

Subclinical Ultrasonographic Enthesopathy and Synovitis in patients with Inflammatory Bowel Disease (IBD) without clinical signs or symptoms of Spondyloarthritis

Authors:

E. Vicente*1, 2, S. Pérez2, L. Merino1, I. Llorente1, M. Chaparro3, F. Rodríguez-Salvanés4, L. Vega4, S. Castañeda1, J.P. Gisbert3

1Hospital Universitario de La Princesa, IIS-IP, Rheumatology Unit, Madrid, Spain, 2Fundación Jiménez Díaz, Madrid, Spain, 3Hospital Universitario de La Princesa, IIS-IP and CIBERehd, Gastroenterology Unit, Madrid, Spain, 4Hospital Universitario de La Princesa, IIS-IP, Epidemiologic Research Unit, Madrid, Spain

P114.

The influence of obesity on clinical course and behaviour of Crohn's disease

Authors:

S.V. Venkatachalapathy1, V.E. Sayer1, N. Grasso1, A. Salerno2, R. Saleem1, P. Dubois1, G. Chung-Faye1, B. Hayee1, 1King's College Hospital NHS Foundation Trust, Gastroenterology, London, United Kingdom, 2King's College Hospital NHS Foundation Trust, Colorectal Surgery, London, United Kingdom